Brazil · Delayed Price · Currency is BRL Biomm Company Description
Biomm S.A. operates as a biotechnology company in Brazil.
The company offers insulin products for the treatment of diabetes, including AFREZZA, a Human insulin powder for inhalation; GLARGILIN, a glargine insulin; WOSULIN N and WOSULIN R; and Lifepen G, a reusable insulin injection pen.
It also provides Bevyx for the treatment of metastatic colorectal cancer; HERZUMA for the treatment of early-stage and metastatic breast cancer and metastatic gastric cancer with HER2-positive tumors; GHEMAXAN, an anticoagulant for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism, unstable angina, and in cases of acute myocardial infarction; and RANIVISIO for the treatment of vision problems related to abnormal blood vessel growth or fluid buildup in the retina.
Biomm S.A. was incorporated in 2001 and is headquartered in Nova Lima, Brazil.
| Country | Brazil |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 130 |
| CEO | Heraldo Marchezini |
Contact Details
Address: 705 – Lagoa dos Ingleses Nova Lima, 34018-000 Brazil | |
| Phone | 55 31 3299 1000 |
| Website | biomm.com |
Stock Details
| Ticker Symbol | BIOM3 |
| Exchange | Brazil Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | BRL |
| ISIN Number | BRBIOMACNOR2 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Heraldo Carvalho Marchezini | Chief Executive Officer and Member of the Executive Board |
| Marcelo Sáfadi Alvares | Chief Financial Officer and IR |
| Francisco Carlos Marques de Freitas | Director of Technology and Member of the Executive Board |
| Francisco Rafael Costa Jr. | Commercial Director and Member of Executive Board |
| Luciano da Silva Machado | Operations Director and Member of Executive Board |
| Nayara Rodrigues de Souza Cruz | Accountant |